Tenaya Therapeutics shareholders elect all three Class I directors and ratify Deloitte as auditor

Tenaya Therapeutics, Inc.

David Goeddel, Ph.D. elected with 80,444,762 votes for, 8,262,596 withheld.
Jeffrey T. Walsh elected with 70,717,277 for, 17,990,081 withheld.
R. Sanders Williams elected with 70,410,874 for, 18,296,484 withheld.
Ratification of Deloitte & Touche LLP passed with 120,339,858 for, 416,705 against, 192,213 abstain.
Broker non-votes of 32,241,417 on each director nominee; none on auditor ratification.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.